Investigation of Selected Piperazine-2,5-Diones on Their Effect on Cartilage-Related Cells †

: Various chronic inflammatory diseases have become a problem, especially in the Western world. Whether it is inflammation of visceral organs, joints, bones, etc., it is always a physiological reaction of the body, which always tries to eradicate harmful substances and restore tissue homeo-stasis. Unfortunately, prolonged or chronic inflammation often results in damage to the affected tissues. Cartilage damage, diseases such as osteoarthritis, rheumatoid arthritis and arthrosis, are very common. In addition to suppressing inflammation in the joints and around the cartilage, it is advantageous to administer compounds that are capable of stimulating cartilage growth and regenerate damaged tissue. Variously substituted piperazine-2,5-dione derivatives were investigated as compounds with a potential effect on cartilage regeneration. A series of assays were performed to evaluate their cytotoxicity, anti-inflammatory activity, ability to potentiate chondrocyte prolifera-tion, and suppress synovial cell growth. The compounds proved to be completely non-toxic for all used types of cells up to the concentration of 20 µM. Unfortunately, their evaluated biological activity proved to be insignificant in comparison with untreated cells.

[1]  J. Fonseca,et al.  Probiotic Supplementation for Rheumatoid Arthritis: A Promising Adjuvant Therapy in the Gut Microbiome Era , 2021, Frontiers in Pharmacology.

[2]  Win Min Oo,et al.  The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date , 2021, Drug design, development and therapy.

[3]  A. Smoliński,et al.  Synthesis and Hybrid SAR Property Modeling of Novel Cholinesterase Inhibitors † , 2021, International journal of molecular sciences.

[4]  J. Jampílek,et al.  Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems , 2021, Pharmaceutics.

[5]  S. Grässel,et al.  Recent advances in the treatment of osteoarthritis , 2020, F1000Research.

[6]  Tsutomu Takeuchi,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update , 2020, Annals of the Rheumatic Diseases.

[7]  Z. Trávníček,et al.  Investigation of Anti-Inflammatory Potential of N-Arylcinnamamide Derivatives , 2019, Molecules.

[8]  C. Supuran,et al.  Pain Relieving Effect of-NSAIDs-CAIs Hybrid Molecules: Systemic and Intra-Articular Treatments against Rheumatoid Arthritis , 2019, International journal of molecular sciences.

[9]  J. Jampílek,et al.  Investigation of Permeation of Theophylline through Skin Using Selected Piperazine-2,5-Diones , 2019, Molecules.

[10]  J. Jampílek,et al.  Potential of Nanomaterial Applications in Dietary Supplements and Foods for Special Medical Purposes , 2019, Nanomaterials.

[11]  S. Aslani,et al.  Strategies toward rheumatoid arthritis therapy; the old and the new , 2018, Journal of cellular physiology.

[12]  Rona R. Ramsay,et al.  A perspective on multi-target drug discovery and design for complex diseases , 2018, Clinical and Translational Medicine.

[13]  J. Jampílek,et al.  Investigation of permeation of acyclovir through skin using alaptide , 2017 .

[14]  Toru Ogata,et al.  Locomotive Syndrome: Definition and Management , 2016, Clinical Reviews in Bone and Mineral Metabolism.

[15]  Alan Talevi,et al.  Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective , 2015, Front. Pharmacol..

[16]  J. Jampílek,et al.  Alaptide as Transdermal Permeation Modifier , 2015 .

[17]  E. Křepela,et al.  Two-step generation of spirocyclic dipeptides from linear peptide ethyl ester precursors. , 1992, Life sciences.